Guillermina (Gigi) Lozano, Ph.D., Department of Genetics, Division of Discovery Science
In recognition of her trailblazing work uncovering the mechanisms of the p53 tumor suppressor, Guillermina “Gigi” Lozano, Ph.D., chair of Genetics at The University of Texas MD Anderson Cancer Center, has received the 2022 Award for Distinguished Research in the Biomedical Sciences by the Association of American Medical Colleges (AAMC).
The Lozano Lab at MD Anderson main research study is on the mutation of p53 protein genetics and the elaboration of tumors. Learn more.
The MD Anderson scientist and department chair saw something in the DNA of cancer that everyone else overlooked
Guillermina Lozano, Ph.D., chair of Genetics at The University of Texas MD Anderson Cancer Center, has been elected to the prestigious National Academy of Sciences (NAS). Lozano is a pioneer in describing the p53 pathway, a recognized tumor suppressor gene associated with cancer.
Guillermina Lozano, Ph.D., chair of Genetics at The University of Texas MD Anderson Cancer Center, has been elected as a member of the American Academy of Arts and Sciences. Lozano is a pioneer in describing the p53 pathway, a recognized tumor suppressor gene associated with cancer.
Gigi Lozano, Ph.D., chair of Genetics at The University of Texas MD Anderson Cancer Center, has been elected to the 2021 class of Fellows of the AACR Academy in recognition of her pioneering work to describe the p53 tumor suppressor pathway, which is undermined in many cancers.
MD Anderson's Lozano awarded AACR Charlotte...
s Hung and Lozano as Fellows of...
MD Anderson’s chair of Genetics, Guillermina “Gigi” Lozano, Ph.D., is a trailblazer in our understanding of the p53 gene’s role in cancer development.